Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner